Form 8-K - Current report:
SEC Accession No. 0001437749-24-038286
Filing Date
2024-12-23
Accepted
2024-12-23 16:06:16
Documents
19
Period of Report
2024-12-20
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K mnpr20241220_8k.htm   iXBRL 8-K 37492
2 UNDERWRITING AGREEMENT, DATED DECEMBER 20, 2024, BY AND AMONG MONOPAR THERAPEUTI ex_760197.htm EX-1.1 220998
3 FORM OF PRE-FUNDED WARRANT ex_760186.htm EX-4.1 90092
4 LEGAL OPINION OF BAKER & HOSTETLER LLP ex_759781.htm EX-5.1 10628
5 SECURITIES PURCHASE AGREEMENT, DATED DECEMBER 20, 2024, BY AND AMONG MONOPAR THE ex_760188.htm EX-10.1 246192
6 FORM OF REGISTRATION RIGHTS AGREEMENT BY AND AMONG MONOPAR THERAPEUTICS INC. AND ex_760187.htm EX-10.2 109504
  Complete submission text file 0001437749-24-038286.txt   1016673

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA mnpr-20241220.xsd EX-101.SCH 3410
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE mnpr-20241220_def.xml EX-101.DEF 12188
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE mnpr-20241220_lab.xml EX-101.LAB 16397
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mnpr-20241220_pre.xml EX-101.PRE 12458
21 EXTRACTED XBRL INSTANCE DOCUMENT mnpr20241220_8k_htm.xml XML 3058
Mailing Address 1000 SKOKIE BLVD SUITE 350 WILMETTE IL 60091
Business Address 1000 SKOKIE BLVD SUITE 350 WILMETTE IL 60091 8473880349
Monopar Therapeutics (Filer) CIK: 0001645469 (see all company filings)

EIN.: 320463781 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39070 | Film No.: 241573637
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)